Education
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
Earnings Data
Report Date
Feb 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.69Last Year’s EPS
-0.76Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in key clinical programs and a strong financial position, with clear paths to future value creation. However, continuous financial losses and high R&D expenses remain challenges. The sentiment is balanced between the achievements and ongoing challenges.Company Guidance
Completion of ECLIPSE 1 Enrollment
Successfully completed enrollment in ECLIPSE 1, the first registrational Phase III study for hepatitis delta, ahead of schedule. This positions the company well for regulatory submissions with top line data expected by early 2027.
Strong Financial Position
Ended the third quarter with approximately $810.7 million in cash, cash equivalents, and investments, with a projected cash runway extending into mid-2027.
Progress in Oncology Portfolio
Substantial progress in dose escalation for VIR-5500, a PSMA-targeted T-cell engager, with promising potential for future data updates expected in Q1 2026.
Cost Savings and Reduced Expenses
Year-over-year decrease in operating expenses by $46.2 million, driven by restructuring initiatives and lower licensing expenses.
VIR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VIR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $5.40 | $5.12 | -5.19% |
Aug 06, 2025 | $5.08 | $4.35 | -14.37% |
May 07, 2025 | $5.61 | $5.41 | -3.57% |
Feb 26, 2025 | $9.20 | $8.11 | -11.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vir Biotechnology (VIR) report earnings?
Vir Biotechnology (VIR) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
What is Vir Biotechnology (VIR) earnings time?
Vir Biotechnology (VIR) earnings time is at Feb 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VIR EPS forecast?
VIR EPS forecast for the fiscal quarter 2025 (Q4) is -0.69.